| J2350 | Injection, ocrelizumab, 1 mg | 9 | 10 | 310 | $20,560 | $10M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 20 | 150 | 4,030 | $100 | $5.9M |
| J9271 | Injection, pembrolizumab, 1 mg | 12 | 20 | 360 | $8,480 | $5M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 12 | 170 | 4,660 | $300 | $2.6M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 43 | 480 | 4,510 | $90 | $1.8M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 78 | 660 | 460 | $90 | $1.5M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 22 | 580 | 510 | $100 | $1.3M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 20 | 140 | 1,130 | $90 | $1.1M |
| 69436 | This procedure is a tympanostomy requiring the insertion of a ventilation tube under general anesthesia. | 46 | 80 | 100 | $860 | $719.1K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 30 | 60 | 250 | $730 | $707.7K |